The Albinism Drug Market is evolving as a critical niche within the global rare disease therapeutics landscape, supported by increasing awareness, technological advancements, and a growing focus on genetic disorders. Albinism, a hereditary condition that affects melanin production, requires comprehensive management strategies that address both dermatological and ophthalmic complications....